Lazzer Stefano, Gatti Alessandro, D'Alleva Mattia, Mari Lara, Zaccaron Simone, Stafuzza Jacopo, Rejc Enrico, Bondesan Adele, Caroli Diana, Frigerio Francesca, Abbruzzese Laura, Ventura Enrica, Grugni Graziano, Sartorio Alessandro
Department of Medicine, University of Udine, 33100 Udine, Italy.
School of Sport Sciences, University of Udine, 33100 Udine, Italy.
J Clin Med. 2025 Apr 12;14(8):2646. doi: 10.3390/jcm14082646.
: This study compared metabolic syndrome (MetS) features in patients with Prader-Willi syndrome (PWS) to those in age-, BMI-, and gender-matched subjects with essential obesity (EOB). : Thirty-two PWS patients (23 females, 9 males; median age 31.6 years; BMI 42.0 kg/m) underwent several assessments, including anthropometric measurements, body composition via bio-impedance analysis, basal metabolic rate (BMR) using indirect calorimetry, and blood sampling. : Their data were compared to a matched EOB group (23 females, 9 males; median age 31.4 years; BMI 43.5 kg/m). The study groups (PWS and EOB) were subsequently divided into two subgroups based on the International Diabetes Federation criteria for the definition of MetS. Results showed that individuals with PWS had significantly lower ( < 0.001) body weight (BW, -20.9%), height (-8.9%), fat-free mass (FFM, -23.5%), and fat mass (FM, -19.2%) in absolute terms compared to EOB subjects. However, the relative percentages of FFM and FM were similar. Absolute BMR was 25.5% ( < 0.001) lower in the PWS group; however, this difference disappeared when adjusted for FFM or body weight (BW). Metabolic outcomes were broadly similar between the groups, except for higher fasting glucose (+7.3%) and HbA1c levels (+7.9%), and lower fasting insulin (-29.0%) in PWS patients. : Moreover, PWS subjects exhibited higher total cholesterol (+9.6%) and HDL-cholesterol (+19.8%), suggesting a more favourable lipid profile and no extra risk beyond severe obesity.
本研究比较了普拉德-威利综合征(PWS)患者与年龄、体重指数(BMI)和性别匹配的单纯性肥胖(EOB)受试者的代谢综合征(MetS)特征。32例PWS患者(23例女性,9例男性;中位年龄31.6岁;BMI 42.0kg/m²)接受了多项评估,包括人体测量、通过生物电阻抗分析测定身体成分、使用间接测热法测定基础代谢率(BMR)以及采血。他们的数据与匹配的EOB组(23例女性,9例男性;中位年龄31.4岁;BMI 43.5kg/m²)进行了比较。随后,根据国际糖尿病联盟(IDF)代谢综合征的定义标准,将研究组(PWS和EOB)分为两个亚组。结果显示,与EOB受试者相比,PWS患者的体重(BW,-20.9%)、身高(-8.9%)、去脂体重(FFM,-23.5%)和脂肪量(FM,-19.2%)绝对值显著更低(P<0.001)。然而,FFM和FM的相对百分比相似。PWS组的绝对BMR低25.5%(P<0.001);然而,在根据FFM或体重(BW)进行调整后,这种差异消失。除了PWS患者的空腹血糖(+7.3%)和糖化血红蛋白(HbA1c)水平(+7.9%)更高,空腹胰岛素(-29.0%)更低外,两组之间的代谢结果大致相似。此外,PWS受试者的总胆固醇(+9.6%)和高密度脂蛋白胆固醇(HDL-C,+19.8%)更高,表明其血脂谱更有利,且除严重肥胖外无额外风险。